Cargando…
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
Pfs230 is essential for Plasmodium falciparum transmission to mosquitoes and is the protein targeted by the most advanced malaria-transmission-blocking vaccine candidate. Prior understanding of functional epitopes on Pfs230 is based on two monoclonal antibodies (mAbs) with moderate transmission-redu...
Autores principales: | Ivanochko, Danton, Fabra-García, Amanda, Teelen, Karina, van de Vegte-Bolmer, Marga, van Gemert, Geert-Jan, Newton, Jocelyn, Semesi, Anthony, de Bruijni, Marloes, Bolscher, Judith, Ramjith, Jordache, Szabat, Marta, Vogt, Stefanie, Kraft, Lucas, Duncan, Sherie, Lee, Shwu-Maan, Kamya, Moses R., Feeney, Margaret E., Jagannathan, Prasanna, Greenhouse, Bryan, Sauerwein, Robert W., Richter King, C., MacGill, Randall S., Bousema, Teun, Jore, Matthijs M., Julien, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942874/ https://www.ncbi.nlm.nih.gov/pubmed/36792575 http://dx.doi.org/10.1016/j.immuni.2023.01.013 |
Ejemplares similares
-
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes
por: Fabra-García, Amanda, et al.
Publicado: (2023) -
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
por: Singh, Susheel K., et al.
Publicado: (2021) -
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
por: Singh, Susheel K., et al.
Publicado: (2019) -
The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania
por: Bousema, Teun, et al.
Publicado: (2010) -
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses
por: McLeod, Brandon, et al.
Publicado: (2022)